In an effort to give you the best possible service, we would be grateful if you could take a few minutes of your time to answer a few questions.
My Saved Results
Join Our Mailing List
Home / Clinical Trials / Find Clinical Trials / A Phase 1, Multicenter, Open-Label, Dose-escalation Study to...
I'm a new user and need a user account
Forgot your password?
The purpose of this study is to determine the maximum tolerated dose (MTD) of pomalidomide in combination with bortezomib and low-dose dexamethasone in subjects with relapsed or refractory multiple myeloma
Winship Cancer Institute of Emory University1365 Clifton Road NEBuilding CAtlanta, GA 30322404-778-5180winshipcancer.emory.edu